LMF
FURX

LMR Master Fund’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

LMR Master Fund’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$244K Buy
+5,822
New +$239K 0.03% 308

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LMR Master Fund's FURX Position: Q4 2013 in Review

LMR Master Fund opened a new position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q4 2013: 5,822 shares worth $244K. The stake represents 0.03% of the portfolio and ranks #308 among its holdings.

84 funds tracked by Wall St. Rank hold FURX as of Q4 2013.

  • LMR Master Fund held 5,822 shares of FURIEX PHARMACEUTICALS INC COM STK (DE) worth $244K as of Q4 2013.
  • FURIEX PHARMACEUTICALS INC COM STK (DE) was a new LMR Master Fund position in Q4 2013.
  • FURIEX PHARMACEUTICALS INC COM STK (DE) made up 0.03% of LMR Master Fund's portfolio in Q4 2013, its #308 holding.
  • 84 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.